Citation: | ZHU Yanan, ZHANG Zhiqiang, ZHU Yunxia. Value of serum angiopoietin-like protein 2 and secreted frizzled-related protein 5 in predicting postoperative coronary slow flow in patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 11-15, 20. DOI: 10.7619/jcmp.20222734 |
To explore the value of serum angiopoietin-like protein 2 (ANGPTL2) and secreted frizzled-related protein 5 (SFRP5) levels in predicting coronary slow flow (CSF) after percutaneous coronaryintervention (PCI) in patients with acute coronary syndrome (ACS).
A total of 182 patients with ACS who underwent PCI were regarded as the research subjects. According to whether the patients developed CSF after PCI, they were grouped into CSF group (42 cases) and normal blood flow group (140 cases). Enzyme-linked immunosorbent assay (ELISA) was performed to detect the levels of serum ANGPTL2 and SFRP5 in ACS patients before PCI. Pearson correlation was performed to analyze the correlation between the levels of serum ANGPTL2 and SFRP5 in the CSF group before PCI. Multivariate Logistic regression was performed to analyze the risk factors of CSF after PCI in ACS patients; receiver operating characteristic (ROC) curve was performed to evaluate the predictive value of levels of serum ANGPTL2 and SFRP5 for CSF in patients with ACS after PCI.
The level of serum ANGPTL2 in the CSF group was (3.48±0.66) ng/mL, which was significantly higher than (2.80±0.51) ng/mL in the normal blood flow group (P < 0.05); the level of serum SFRP5 in the CSF group was (14.85±4.04) ng/mL, which was significantly lower than (22.12±4.69) ng/mL in the normal blood flow group (P < 0.05). There was a significant negative correlation between serum ANGPTL2 and SFRP5 before PCI in CSF group (r=-0.661, P < 0.001). High level of serum ANGPTL2 and low level of SFRP5 before PCI were risk factors for CSF in patients with ACS after PCI. The area under the ROC curve (AUC) of ANGPTL2 and SFRP5 in predicting CSF after PCI was significantly greater than that predicted by ANGPTL2 alone (Z=2.206, P=0.014) and by SFRP5 alone (Z=1.696, P=0.045).
Serum ANGPTL2 and SFRP5 levels are the factors influencing the occurrence of CSF after PCI. The increased level of ANGPTL2 and decreased level of SFRP5 before and after PCI in patients with ACS are associated with the occurrence of CSF after PCI. The combined detection has predictive value for the occurrence of CSF after PCI in patients with ACS.
[1] |
DU G L, LUO J Y, WANG D L, et al. MIF gene rs755622 polymorphism positively associated with acute coronary syndrome in Chinese Han population: case-control study[J]. Sci Rep, 2020, 10(1): 140. doi: 10.1038/s41598-019-56949-z
|
[2] |
ZHANG X Y, TIAN G H, SHI Z F, et al. Initiate Danhong Injection before or after percutaneous coronary intervention for microvascular obstruction in ST-elevation myocardial infarction (DIRECTION): study protocol for a randomized controlled trial[J]. Trials, 2020, 21(1): 48. doi: 10.1186/s13063-019-3947-6
|
[3] |
THORIN-TRESCASES N, LABBÉ P, MURY P, et al. Angptl2 is a marker of cellular senescence: the physiological and pathophysiological impact of Angptl2-related senescence[J]. Int J Mol Sci, 2021, 22(22): 12232. doi: 10.3390/ijms222212232
|
[4] |
CAO Y J, LI R Q, ZHANG F P, et al. Correlation between angiopoietin-like proteins in inflammatory mediators in peripheral blood and severity of coronary arterial lesion in patients with acute myocardial infarction[J]. Exp Ther Med, 2019, 17(5): 3495-3500.
|
[5] |
NGUYEN A, MAMARBACHI M, TURCOT V, et al. Lower methylation of the ANGPTL2 gene in leukocytes from post-acute coronary syndrome patients[J]. PLoS One, 2016, 11(4): e0153920. doi: 10.1371/journal.pone.0153920
|
[6] |
王康, 智丽霞, 石姣姣, 等. 冠心病患者血浆白脂素和分泌型卷曲相关蛋白5与冠状动脉病变程度的相关性[J]. 临床心血管病杂志, 2022, 38(6): 455-460. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB202206016.htm
|
[7] |
DU Y, ZHAO Y X, ZHU Y, et al. High serum secreted frizzled-related protein 5 levels associates with early improvement of cardiac function following ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention[J]. J Atheroscler Thromb, 2019, 26(10): 868-878. doi: 10.5551/jat.47019
|
[8] |
HU F, LU F, HUANG X, et al. Relationship between plasma total homocysteine levels and mean corrected TIMI frame count in patients with acute myocardial infarction[J]. Int J Gen Med, 2021, 14: 8161-8172. doi: 10.2147/IJGM.S338938
|
[9] |
中国医师协会急诊医师分会, 国家卫健委能力建设与继续教育中心急诊学专家委员会, 中国医疗保健国际交流促进会急诊急救分会. 急性冠状动脉综合征急诊快速诊治指南(2019)[J]. 中国急救医学, 2019, 39(4): 301-308. doi: 10.3969/j.issn.1002-1949.2019.04.001
|
[10] |
季鹏, 孙伟, 贾玉卿. IL-16联合GRACE出院评分对老年非ST段抬高型急性冠状动脉综合征病人不良心脑血管事件的预测价值[J]. 实用老年医学, 2021, 35(9): 939-942, 947. doi: 10.3969/j.issn.1003-9198.2021.09.012
|
[11] |
胡盛寿, 高润霖, 刘力生, 等. 《中国心血管病报告2018》概要[J]. 中国循环杂志, 2019, 34(3): 209-220. doi: 10.3969/j.issn.1000-3614.2019.03.001
|
[12] |
张姝, 赵洪震, 兰海峰. 彩色多普勒超声检测动脉内中膜厚度、血管舒张功能在预测冠心病发生中的价值[J]. 实用临床医药杂志, 2019, 23(6): 17-20. doi: 10.7619/jcmp.201906004
|
[13] |
王冲冲, 邓天明, 王艳红. 温胆汤对急性冠状动脉综合征经皮冠状动脉介入术后患者脂蛋白磷脂酶A2的影响[J]. 广州中医药大学学报, 2022, 39(6): 1262-1267. https://www.cnki.com.cn/Article/CJFDTOTAL-REST202206007.htm
|
[14] |
俞春霞, 蔡薇. 急性冠脉综合征患者多项生化标志物检测及预后分析[J]. 实用临床医药杂志, 2017, 21(13): 196-197. doi: 10.7619/jcmp.201713068
|
[15] |
TASAR O, KARABAY A K, ODUNCU V, et al. Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Coron Artery Dis, 2019, 30(4): 270-276. doi: 10.1097/MCA.0000000000000726
|
[16] |
王琰, 李永星, 郭华, 等. 急性心肌梗死急诊经皮冠状动脉介入术后慢血流/无复流的相关因素研究[J]. 中国现代医学杂志, 2022, 32(7): 24-30. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXDY202207017.htm
|
[17] |
LI H Y, SUN K, ZHAO R P, et al. Inflammatory biomarkers of coronary heart disease[J]. Front Biosci (Schol Ed), 2018, 10(1): 185-196. doi: 10.2741/s508
|
[18] |
林灵丹, 许士达, 邢海燕. 白细胞介素-17预测ST段抬高型心肌梗死患者经皮冠状动脉介入术后慢血流或无复流的价值[J]. 实用临床医药杂志, 2021, 25(11): 93-95, 100. doi: 10.7619/jcmp.20210482
|
[19] |
CHEN W G, WANG J B, WANG X H, et al. Knockdown of hypoxia-inducible factor 1-alpha (HIF1α) interferes with angiopoietin-like protein 2 (ANGPTL2) to attenuate high glucose-triggered hypoxia/reoxygenation injury in cardiomyocytes[J]. Bioengineered, 2022, 13(1): 1476-1490.
|
[20] |
AKOUMIANAKIS I, SANNA F, MARGARITIS M, et al. Adipose tissue-derived WNT5A regulates vascular redox signaling in obesity via USP17/RAC1-mediated activation of NADPH oxidases[J]. Sci Transl Med, 2019, 11(510): eaav5055.
|
[21] |
HUANG X, YAN Y, ZHENG W, et al. Secreted frizzled-related protein 5 protects against cardiac rupture and improves cardiac function through inhibiting mitochondrial dysfunction[J]. Front Cardiovasc Med, 2021, 8: 682409.
|
[22] |
TONG S, JI Q W, DU Y, et al. Sfrp5/wnt pathway: a protective regulatory system in atherosclerotic cardiovascular disease[J]. J Interferon Cytokine Res, 2019, 39(8): 472-482.
|